Hyperprolactinemia in multiple sclerosis
- 31 March 1991
- journal article
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 102 (1) , 61-66
- https://doi.org/10.1016/0022-510x(91)90094-n
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Education, Culture, Sports, Science and Technology
This publication has 28 references indexed in Scilit:
- Klinische Studien über die Anwendung von Roxatidinacetat in der Behandlung des Ulcus pepticum in JapanDrugs, 1988
- Glucocorticoid suppression enhances the 18-hydroxycorticosterone and aldosterone response to metoclopramide in manLife Sciences, 1983
- New diagnostic criteria for multiple sclerosis: Guidelines for research protocolsAnnals of Neurology, 1983
- Pituitary Function in the Empty Sella SyndromeNeuroendocrinology, 1981
- Metabolic Effects of Chronic Prazosin TreatmentHormone and Metabolic Research, 1980
- Prolactin-Releasing Effect of Domperidone in Normoprolactinemic and Hyperprolactinemic SubjectsNeuroendocrinology, 1980
- THE DIAGNOSTIC VALUE OF PHARMACODYNAMIC TESTS IN THE HYPERPROLACTINAEMIC SYNDROMEClinical Endocrinology, 1979
- TESTS OF PROLACTIN SECRETION IN DIAGNOSIS OF PROLACTINOMASThe Lancet, 1979
- INTERNATIONAL REFERENCE PREPARATION OF HUMAN PROLACTIN FOR IMMUNOASSAY: DEFINITION OF THE INTERNATIONAL UNIT, REPORT OF A COLLABORATIVE STUDY AND COMPARISON OF ESTIMATES OF HUMAN PROLACTIN MADE IN VARIOUS LABORATORIESJournal of Endocrinology, 1979
- In Vitro Cell-Mediated Immunity of Cerebrospinal-Fluid Lymphocytes to Myelin Basic Protein in Primary Demyelinating DiseasesNew England Journal of Medicine, 1977